View of CLINICAL OUTCOMES OF LONG-TERM USE OF SGLT2 INHIBITORS IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE

Return to Issue Details CLINICAL OUTCOMES OF LONG-TERM USE OF SGLT2 INHIBITORS IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE Download Download PDF